simvastatin has been researched along with Coronary Restenosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, C; Li, M; Xiao, W; Xu, W; Yu, J | 1 |
Amrein, K; Binder, J; Cvirn, G; Ferstl, U; Froehlich, H; Hallström, S; Hörl, G; Jürgens, G; Koidl, C; Ledinski, G; Scharnagl, H; Stojakovic, T; Tafeit, E; Trauner, M | 1 |
Gao, E; Li, D; Pei, H; Tang, L; Wang, T; Wang, X; Yang, D; Yang, Y | 1 |
Ahn, Y; Baek, JY; Cho, JG; Cho, JS; Her, SH; Hong, YJ; Jeong, MH; Jin, SW; Kang, JC; Kim, HD; Kim, JH; Lim, KS; Park, JC; Sim, DS; Yoon, HJ | 1 |
Balvedi, J; Bergoli, LC; Iturry-Yamamoto, G; Krepsky, A; Matte, BS; Raudales, JC; Reginato, L; Saadi, EK; Zago, AC; Zago, AJ | 1 |
Duncan, E; Nageh, T; Thomas, MR | 1 |
Amoroso, G; Ciabatti, N; De Carlo, M; Limbruno, U; Mariani, M; Micheli, A; Papini, B; Petronio, AS | 1 |
2 trial(s) available for simvastatin and Coronary Restenosis
Article | Year |
---|---|
First-in-man study of simvastatin-eluting stent in de novo coronary lesions: the SIMVASTENT study.
Topics: Aged; Anticholesteremic Agents; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Neointima; Simvastatin; Sirolimus; Ultrasonography, Interventional | 2012 |
Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Male; Middle Aged; Premedication; Simvastatin; Stents; Ultrasonography, Interventional | 2005 |
5 other study(ies) available for simvastatin and Coronary Restenosis
Article | Year |
---|---|
Simvastatin decreases stent-induced in-stent restenosis rate via downregulating the expression of PCNA and upregulating that of p27kip1.
Topics: Animals; Blotting, Western; Cell Cycle; Cell Proliferation; Coronary Artery Disease; Coronary Restenosis; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Down-Regulation; Immunohistochemistry; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Proliferating Cell Nuclear Antigen; Rabbits; Random Allocation; Simvastatin; Stents; Up-Regulation | 2013 |
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.
Topics: Adult; Aged; Aged, 80 and over; Antigen-Antibody Complex; Apolipoproteins B; Cholesterol, LDL; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Male; Malondialdehyde; Middle Aged; Peripheral Arterial Disease; Simvastatin | 2016 |
The inhibition of calpains ameliorates vascular restenosis through MMP2/TGF-β1 pathway.
Topics: Animals; Calcium-Binding Proteins; Calpain; Carotid Arteries; Cell Movement; Cell Proliferation; Collagen; Coronary Restenosis; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; RNA, Small Interfering; Signal Transduction; Simvastatin; Transforming Growth Factor beta1 | 2016 |
Effects of combined therapy with ezetimibe plus simvastatin after drug-eluting stent implantation in a porcine coronary restenosis model.
Topics: Animals; Anticholesteremic Agents; Azetidines; Coronary Restenosis; Disease Models, Animal; Drug Combinations; Drug Implants; Drug-Eluting Stents; Ezetimibe; Female; Graft Occlusion, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin; Swine; Treatment Outcome | 2010 |
Regression of coronary in-stent restenosis.
Topics: Adult; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Humans; Hypercholesterolemia; Male; Simvastatin; Stents; Ultrasonography, Interventional | 2004 |